BIESF Biotest AG — dividend yield, history & ex-dividend dates
Biotest Aktiengesellschaft, a German biopharmaceutical company established in Dreieich in 1946, specializes in the research, development, production, and global commercialization of advanced biological therapeutics. Its operations are organized into key segments: Therapy, Plasma & Services, and Other. The company’s primary focus areas encompass critical medical needs within hematology (blood disorders), clinical immunology, and intensive care medicine. Biotest offers a comprehensive range of products, including specific treatments for hemophilia like Haemoctin and Vihuma for the acute and prophylactic management of hemophilia A, and Haemonine for similar applications in hemophilia B. Its portfolio also features immunotherapies such as Cytotect CP biotest for cytomegalovirus infections, Fovepta for hepatitis B prophylaxis in neonates, and Hepatect for preventing hepatitis B reinfection. Varitect addresses varicella zoster virus infections, while Intratect and IgG Next Generation are utilized for primary immune and secondary antibody deficiency syndromes, autoimmune conditions, and certain neurological indications. Additionally, Zutectra is available for hepatitis B re-infection prophylaxis following liver transplantation. Further extending its product line, Biotest provides solutions like Albiomin and Biseko to restore and sustain circulating blood volume, Cofact for clotting factor deficiencies, and Fibrinogen for congenital fibrinogen deficiency. Innovative treatments include Trimodulin for community-acquired pneumonia and COVID-19, as well as Pentaglobin for bacterial infections. Known as Biotest Serum-Institut GmbH until its renaming in 1986, the company has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
Dividend Snapshot
Key Metrics
Current Yield
0.14%
At the Sep 14, 2026 price
The annual dividend as a percentage of the share price. A 3% yield is about $3 of dividends a year for every $100 invested at today's price.Annualized Dividend
$0.0455
The most recent payment scaled to a full year by how often it's paid. A $0.25 quarterly dividend annualizes to $1.00.Frequency
A Annual
How often the dividend is paid: Q = quarterly (4x a year), M = monthly, S = semi-annual, A = annual.Rank Score
28.2
As of Sep 14, 2026
Our 0-100 house score blending yield quality, payout sustainability (the trailing-twelve-month payout ratio), profitability (TTM return on equity), valuation (TTM price-to-book) and payment reliability, recomputed daily. Higher means a stronger profile on those factors in our model — a research score, not advice or a recommendation to buy.RSI (14)
100
As of Sep 14, 2026
Relative Strength Index (0-100), a price-momentum gauge. Above 70 is often called 'overbought', below 30 'oversold'. A technical signal, not a dividend metric.52-Week Range
$32.00 – $32.00
Closes through Jun 09, 2025
The lowest and highest price over the past year — shows where today's price sits in its recent range.Payout Ratio (FY2025)
n/a
Fiscal year to Dec 31, 2025
The share of earnings paid out as dividends over the trailing twelve months (TTM): dividends paid divided by net income across the company's four most recent reported quarters, dated by the latest quarter end. A fiscal-year tag such as FY2025 means only annual figures were available. Lower leaves more cushion; above 100% means paying out more than the company earned. It shows n/a for funds and when net income over the period was negative; for REITs and BDCs it is marked EPS-based, since they are judged on FFO/AFFO or net investment income instead.Years Paying
38
How many years of payments we have on record. This can understate very long histories where our data doesn't reach far enough back.Price / Book (FY2025)
2.33
At fiscal year-end, Dec 31, 2025
Price-to-book ratio: the share price on the date shown divided by the latest reported book value per share. A rough valuation gauge, most useful for asset-heavy sectors like REITs, banks and insurers.S.A.F.E. Dividend Read
Quote & Key Data
Dividend Growth
Adjusted Price History
Dividend History
Dividend Payment History
Ex-dividend calendar →| Amount | Type | Declared | Ex-Date | Record | Pay |
|---|---|---|---|---|---|
| $0.0455 A | Regular | Jun 12, 2026 | Jul 23, 2026 | Jul 23, 2026 | Jul 24, 2026 |
| $0.0458 A | Regular | - | Jul 22, 2026 | Jul 23, 2026 | Jul 24, 2026 |
| $0.0470 A | Regular | May 21, 2025 | Jul 03, 2025 | Jul 04, 2025 | Jul 07, 2025 |
| $0.0430 A | Regular | Mar 28, 2024 | May 08, 2024 | May 09, 2024 | May 13, 2024 |
| $0.0423 A | Regular | Mar 29, 2022 | May 06, 2022 | May 09, 2022 | May 10, 2022 |
| $0.0483 A | Regular | Mar 30, 2021 | May 12, 2021 | May 13, 2021 | May 17, 2021 |
| $0.0433 A | Regular | Apr 08, 2020 | May 11, 2020 | May 12, 2020 | May 13, 2020 |
| $0.0448 A | Regular | Mar 28, 2019 | May 08, 2019 | May 09, 2019 | May 10, 2019 |
| $0.0471 A | Regular | Apr 04, 2018 | May 16, 2018 | May 17, 2018 | May 18, 2018 |
| $0.0833 A | Regular | Jul 20, 2017 | Aug 31, 2017 | - | Sep 04, 2017 |
| $0.0452 A | Regular | Mar 24, 2016 | May 13, 2016 | - | May 13, 2016 |
| $0.7419 A | Regular | Mar 25, 2015 | May 08, 2015 | - | May 08, 2015 |
| $0.8734 A | Regular | Mar 26, 2014 | May 08, 2014 | - | May 08, 2014 |
| $0.7339 A | Regular | - | May 09, 2013 | - | May 10, 2013 |
| $0.6469 A | Regular | - | May 11, 2012 | - | May 11, 2012 |
| $0.6222 A | Regular | - | May 13, 2011 | - | May 13, 2011 |
| $0.5087 A | Regular | - | May 07, 2010 | - | May 07, 2010 |
| $0.4854 A | Regular | - | May 08, 2009 | - | May 08, 2009 |
| $0.5636 A | Regular | - | May 28, 2008 | - | May 28, 2008 |
| $0.4076 A | Regular | - | May 04, 2007 | - | May 04, 2007 |
| $0.2321 A | Regular | - | May 12, 2006 | - | May 12, 2006 |
| $0.1382 A | Regular | - | May 23, 2005 | - | May 23, 2005 |
| $0.2726 A | Regular | - | Jul 09, 2004 | - | Jul 09, 2004 |
| $0.3067 A | Regular | - | Jul 12, 2002 | - | Jul 12, 2002 |
| $0.2647 A | Regular | - | Jul 13, 2001 | - | Jul 13, 2001 |
| $0.2440 A | Regular | - | Jul 17, 2000 | - | Jul 17, 2000 |
| $0.2609 A | Regular | - | Jul 16, 1999 | - | Jul 16, 1999 |
| $0.5485 A | Regular | - | Jul 10, 1998 | - | Jul 10, 1998 |
| $0.5574 A | Regular | - | Jul 21, 1997 | - | Jul 21, 1997 |
| $5.3680 A | Regular | - | Jul 22, 1996 | - | Jul 22, 1996 |
| $5.7784 A | Regular | - | Jul 24, 1995 | - | Jul 24, 1995 |
| $4.4058 A | Regular | - | Jul 25, 1994 | - | Jul 25, 1994 |
| $3.4782 A | Regular | - | Jul 26, 1993 | - | Jul 26, 1993 |
| $5.3832 A | Regular | - | Jul 27, 1992 | - | Jul 27, 1992 |
| $4.4656 A | Regular | - | Jul 15, 1991 | - | Jul 15, 1991 |
| $4.7696 A | Regular | - | Jun 25, 1990 | - | Jun 25, 1990 |
| $4.1984 A | Regular | - | Jul 24, 1989 | - | Jul 24, 1989 |
| $1.0892 A | Regular | - | Jul 25, 1988 | - | Jul 25, 1988 |
Peer Comparison
Selected Biotechnology dividend payers we cover, strongest DividendRank first — for context, not a recommendation.
| Ticker | Name | Yield | 5-Yr Growth | Streak | Rank |
|---|---|---|---|---|---|
| TRSBF | 3SBio Inc. | 1.48% | - | 0 yrs | 62 |
| XOMAP | XOMA Corporation | 8.63% | - | 0 yrs | 54 |
| XOMAO | XOMA Corporation | 8.38% | - | 0 yrs | 52 |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.48% | - | 0 yrs | 45 |
Related Guides & Lists
BIESF dividend — frequently asked questions
Does Biotest AG pay a dividend?
Yes. Biotest AG (BIESF) currently pays a dividend. The annualized dividend is about $0.05 per share, a yield of approximately 0.14%.
What is Biotest AG's dividend yield?
Biotest AG's dividend yield is approximately 0.14%, based on the most recent regular payment annualized against the current share price. Yields move as the share price changes.
How often does Biotest AG pay dividends?
Biotest AG pays dividends annually — 1 time per year.
How long has Biotest AG paid dividends?
Biotest AG has 38 years of dividend payments on record.
Data updated Sep 14, 2026. This research page is generated from Dividendly's structured market and dividend dataset using the approach described on our methodology and data sources pages. Data is automatically validated using defined rules and may also be periodically reviewed. Research only, not investment advice. Spotted a data error? Report it.